Literature DB >> 31808575

CTRP3 Regulates Endochondral Ossification and Bone Remodeling During Fracture Healing.

Daniel W Youngstrom1,2, Robert L Zondervan1,3, Nicole R Doucet1, Parker K Acevedo1, Hannah E Sexton1, Emily A Gardner1, JonCarlos S Anderson1, Priyanka Kushwaha4, Hannah C Little5, Susana Rodriguez5, Ryan C Riddle4, Ivo Kalajzic6, G William Wong5, Kurt D Hankenson1.   

Abstract

C1q/TNF-related protein 3 (CTRP3) is a cytokine known to regulate a variety of metabolic processes. Though previously undescribed in the context of bone regeneration, high throughput gene expression experiments in mice identified CTRP3 as one of the most highly upregulated genes in fracture callus tissue. Hypothesizing a positive regulatory role for CTRP3 in bone regeneration, we phenotyped skeletal development and fracture healing in CTRP3 knockout (KO) and CTRP3 overexpressing transgenic (TG) mice relative to wild-type (WT) control animals. CTRP3 KO mice experienced delayed endochondral fracture healing, resulting in abnormal mineral distribution, the presence of periosteal marrow compartments, and a nonunion-like state. Decreased osteoclast number was also observed in CTRP3 KO mice, whereas CTRP3 TG mice underwent accelerated callus remodeling. Gene expression profiling revealed a broad impact on osteoblast/osteoclast lineage commitment and metabolism, including arrested progression toward mature skeletal lineages in the KO group. A single systemic injection of CTRP3 protein at the time of fracture was insufficient to phenocopy the chronic TG healing response in WT mice. By associating CTRP3 levels with fracture healing progression, these data identify a novel protein family with potential therapeutic and diagnostic value.
© 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 38:00-19966, 2020. © 2019 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.

Entities:  

Keywords:  CTRP3; bone; fracture healing; nonunion; regeneration

Mesh:

Substances:

Year:  2019        PMID: 31808575      PMCID: PMC7162724          DOI: 10.1002/jor.24553

Source DB:  PubMed          Journal:  J Orthop Res        ISSN: 0736-0266            Impact factor:   3.102


  30 in total

Review 1.  CTRP family: linking immunity to metabolism.

Authors:  Andreas Schäffler; Christa Buechler
Journal:  Trends Endocrinol Metab       Date:  2012-01-17       Impact factor: 12.015

Review 2.  C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation.

Authors:  Ying Li; Gary L Wright; Jonathan M Peterson
Journal:  Compr Physiol       Date:  2017-06-18       Impact factor: 9.090

3.  CTRP3 is Significantly Decreased in Patients with Primary Hyperparathyroidism and Closely Related with Osteoporosis.

Authors:  Derya Demirtas; Fettah Acıbucu; Filiz Alkan Baylan; Erdinc Gulumsek; Tayyibe Saler
Journal:  Exp Clin Endocrinol Diabetes       Date:  2019-05-22       Impact factor: 2.949

4.  Serum CTRP3 Level is Associated with Osteoporosis in Postmenopausal Women.

Authors:  Zhong-Hua Xu; Xing Zhang; Hua Xie; Jin He; Wen-Chao Zhang; Dan-Feng Jing; Xiang Luo
Journal:  Exp Clin Endocrinol Diabetes       Date:  2018-02-08       Impact factor: 2.949

5.  The biology of fracture healing.

Authors:  Richard Marsell; Thomas A Einhorn
Journal:  Injury       Date:  2011-04-13       Impact factor: 2.586

6.  CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.

Authors:  Ju-Young Kim; Jung-Youl Min; Jong Min Baek; Sung-Jun Ahn; Hong Young Jun; Kwon-Ha Yoon; Min Kyu Choi; Myeung Su Lee; Jaemin Oh
Journal:  Bone       Date:  2015-06-21       Impact factor: 4.398

7.  Cartducin stimulates mesenchymal chondroprogenitor cell proliferation through both extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways.

Authors:  Hironori Akiyama; Souhei Furukawa; Satoshi Wakisaka; Takashi Maeda
Journal:  FEBS J       Date:  2006-05       Impact factor: 5.542

8.  Analysis of αSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing.

Authors:  Brya G Matthews; Danka Grcevic; Liping Wang; Yusuke Hagiwara; Hrvoje Roguljic; Pujan Joshi; Dong-Guk Shin; Douglas J Adams; Ivo Kalajzic
Journal:  J Bone Miner Res       Date:  2014       Impact factor: 6.741

9.  Intraoperative delivery of the Notch ligand Jagged-1 regenerates appendicular and craniofacial bone defects.

Authors:  Daniel W Youngstrom; Rafael Senos; Robert L Zondervan; Jack D Brodeur; Austin R Lints; Devin R Young; Troy L Mitchell; Megan E Moore; Marc H Myers; Wei-Ju Tseng; Kathleen M Loomes; Kurt D Hankenson
Journal:  NPJ Regen Med       Date:  2017-12-15

10.  Tibia shaft fractures: costly burden of nonunions.

Authors:  Evgeniya Antonova; T Kim Le; Russel Burge; John Mershon
Journal:  BMC Musculoskelet Disord       Date:  2013-01-26       Impact factor: 2.362

View more
  4 in total

1.  Notch signaling enhances bone regeneration in the zebrafish mandible.

Authors:  Jessica M Kraus; Dion Giovannone; Renata Rydzik; Jeremy L Balsbaugh; Isaac L Moss; Jennifer L Schwedler; Julien Y Bertrand; David Traver; Kurt D Hankenson; J Gage Crump; Daniel W Youngstrom
Journal:  Development       Date:  2022-03-11       Impact factor: 6.868

2.  CTRP11 contributes modestly to systemic metabolism and energy balance.

Authors:  Dylan C Sarver; Cheng Xu; Dana Carreno; Alexander Arking; Chantelle E Terrillion; Susan Aja; G William Wong
Journal:  FASEB J       Date:  2022-06       Impact factor: 5.834

3.  Core-binding factor beta is required for osteoblast differentiation during fibula fracture healing.

Authors:  Tuanmao Guo; Yanli Xing; Zhongning Chen; Xianhong Wang; Haiyun Zhu; Lan Yang; Yong Yan
Journal:  J Orthop Surg Res       Date:  2021-05-14       Impact factor: 2.359

4.  Plasma C1q/tumor necrosis factor-related protein-3 concentrations are associated with diabetic peripheral neuropathy.

Authors:  Ke Lin; Liu Yang; Yuyuan Xiong; Keduo Feng; Wang Zeng; Bo Deng
Journal:  BMJ Open Diabetes Res Care       Date:  2022-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.